Ovide (malathion) NDC 51672-5293

NDC codes

FDA NDC Directory

Product NDC (as listed)51672-5293Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51672-5293Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51672-5293-4	51672529304	1 BOTTLE in 1 CARTON (51672-5293-4) / 59 mL in 1 BOTTLEMarketed from Jan 31, 2014

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ovide
Generic name (nonproprietary): malathion
Active ingredients: Malathion — .0005 g/mL
Dosage form: Lotion
Route: Topical
Labeler: Sun Pharmaceutical Industries, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091559
Marketing start: Jan 31, 2014
Listing expires: Dec 31, 2027
Other FDA classes: Cholinesterase Inhibitors (Mechanism)
Identifiers: Product ID 51672-5293_56a7269a-5153-0a24-e063-6294a90a12b2SPL ID 56a7269a-5153-0a24-e063-6294a90a12b2SPL set ID 945f46fa-4b79-49fd-a890-477f251e2164UNII U5N7SU872W
Pharmacologic class: Cholinesterase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451672529304 followed by a unit qualifier and the quantity

Package 51672-5293-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 15, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE OVIDE Lotion is indicated for patients infected with Pediculus humanus capitis (head lice and their ova) of the scalp hair.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 091559

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091559
Product	Strength	Form · route	Labeler	Product NDC
Malathion	Malathion .0005 g/mL	LotionTopical	Sun Pharmaceutical Industries, Inc.	51672-5294